{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T20:38:30Z","timestamp":1719952710608},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejphar.2015.05.061","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T09:04:17Z","timestamp":1433581457000},"page":"256-262","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: In vitro vs in vivo comparison using anacetrapib and dalcetrapib"],"prefix":"10.1016","volume":"762","author":[{"given":"Douglas G.","family":"Johns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Castro-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Previs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.ejphar.2015.05.061_bib1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","article-title":"High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport","volume":"124","author":"Assmann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2015.05.061_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nm0797-744","article-title":"High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase","volume":"3","author":"Berard","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2015.05.061_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.ejphar.2015.05.061_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF02938393","article-title":"HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease","volume":"9","author":"Brewer","year":"2007","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ejphar.2015.05.061_bib5","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1194\/jlr.M016410","article-title":"Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters","volume":"52","author":"Castro-Perez","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2015.05.061_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.metabol.2011.08.006","article-title":"Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters","volume":"61","author":"Chen","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2015.05.061_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2760(89)90284-1","article-title":"The rabbit as an animal model of hepatic lipase deficiency","volume":"1002","author":"Clay","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2015.05.061_bib8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0022-2275(20)33480-5","article-title":"Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I","volume":"40","author":"Collet","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2015.05.061_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/327632a0","article-title":"Cloning and sequencing of human cholesteryl ester transfer protein cDNA","volume":"327","author":"Drayna","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.05.061_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2015.05.061_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/clpt.2011.271","article-title":"Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction","volume":"91","author":"Gutstein","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2015.05.061_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0021-9150(83)90043-6","article-title":"Changes in the density distribution of pig high density lipoproteins during incubation in vitro. Influence of esterified cholesterol transfer activity","volume":"48","author":"Ha","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2015.05.061_bib13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1172\/JCI115993","article-title":"Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences","volume":"90","author":"Jiang","year":"1992","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2015.05.061_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11599310-000000000-00000","article-title":"On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors","volume":"72","author":"Johns","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2015.05.061_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0009-8981(81)90146-7","article-title":"Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma","volume":"113","author":"Kirstein","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2015.05.061_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.ATV.0000022850.59845.E0","article-title":"Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I\/A-II in prediction of coronary heart disease: the PRIME study. Prospective epidemiological study of myocardial infarction","volume":"22","author":"Luc","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2015.05.061_bib17","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1016\/S0021-9258(18)43221-8","article-title":"A plasma inhibitor of triglyceride and cholesteryl ester transfer activities","volume":"256","author":"Morton","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.05.061_bib18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2015.05.061_bib19","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1194\/jlr.M008706","article-title":"Modulating cholesteryl ester transfer protein activity maintains efficient pre-beta-HDL formation and increases reverse cholesterol transport","volume":"51","author":"Niesor","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2015.05.061_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35018119","article-title":"A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits","volume":"406","author":"Okamoto","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2015.05.061_bib21","doi-asserted-by":"crossref","first-page":"40859","DOI":"10.1074\/jbc.M306580200","article-title":"Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP)","volume":"278","author":"Paromov","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.05.061_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0005-2760(78)90163-7","article-title":"Cholesteryl ester exchange protein in human plasma isolation and characterization","volume":"530","author":"Pattnaik","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2015.05.061_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tiv.2010.01.002","article-title":"MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophages","volume":"24","author":"Perez","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejphar.2015.05.061_bib24","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1194\/jlr.M007468","article-title":"Biochemical characterization of cholesteryl ester transfer protein inhibitors","volume":"51","author":"Ranalletta","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2015.05.061_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/fca.12.25","article-title":"An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels","volume":"8","author":"Rhainds","year":"2012","journal-title":"Future Cardiol."},{"key":"10.1016\/j.ejphar.2015.05.061_bib26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2015.05.061_bib27","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.M012872","article-title":"siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids","volume":"52","author":"Tadin-Strapps","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2015.05.061_bib28","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1194\/jlr.M041541","article-title":"In vivo effects of anacetrapib on pre\u03b2 HDL: improvement in HDL remodeling without effects on cholesterol absorption","volume":"54","author":"Wang","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2015.05.061_bib29","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","article-title":"Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915300613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915300613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T17:32:01Z","timestamp":1652290321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915300613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"alternative-id":["S0014299915300613"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.061","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: In vitro vs in vivo comparison using anacetrapib and dalcetrapib","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}